Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1990 1
1991 1
1992 1
1994 2
1995 1
1996 4
1997 5
1998 3
1999 6
2000 4
2001 3
2002 2
2003 7
2004 13
2005 5
2006 7
2007 8
2008 10
2009 11
2010 8
2011 8
2012 5
2013 6
2014 4
2015 7
2016 10
2017 15
2018 18
2019 13
2020 7
2021 8
2022 11
2023 17
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Boorjian SA, et al. Among authors: o donnell ma. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27. Lancet Oncol. 2021. PMID: 33253641 Free PMC article. Clinical Trial.
Combination Intravesical Therapy.
Brooks NA, O'Donnell MA. Brooks NA, et al. Among authors: o donnell ma. Urol Clin North Am. 2020 Feb;47(1):83-91. doi: 10.1016/j.ucl.2019.09.010. Urol Clin North Am. 2020. PMID: 31757303 Review.
Reply by Authors.
McElree IM, Steinberg RL, Martin AC, Richards J, Mott SL, Gellhaus PT, Nepple KG, O'Donnell MA, Packiam VT. McElree IM, et al. Among authors: o donnell ma. J Urol. 2022 Sep;208(3):599-600. doi: 10.1097/JU.0000000000002740.04. Epub 2022 Jul 27. J Urol. 2022. PMID: 35892272 No abstract available.
Reply by Authors.
Akiyama Y, Miyakawa J, O'Donnell MA, Kreder KJ, Luo Y, Maeda D, Ushiku T, Kume H, Homma Y. Akiyama Y, et al. Among authors: o donnell ma. J Urol. 2022 Mar;207(3):646. doi: 10.1097/JU.0000000000002278.03. Epub 2021 Dec 7. J Urol. 2022. PMID: 35135333 No abstract available.
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.
Steinberg RL, Thomas LJ, Brooks N, Mott SL, Vitale A, Crump T, Rao MY, Daniels MJ, Wang J, Nagaraju S, DeWolf WC, Lamm DL, Kates M, Hyndman ME, Kamat AM, Bivalacqua TJ, Nepple KG, O'Donnell MA. Steinberg RL, et al. Among authors: o donnell ma. J Urol. 2020 May;203(5):902-909. doi: 10.1097/JU.0000000000000688. Epub 2019 Dec 10. J Urol. 2020. PMID: 31821066
Reply by Authors.
Abou Chakra M, Shore ND, Dillon R, O'Donnell MA. Abou Chakra M, et al. Among authors: o donnell ma. Urol Pract. 2024 Jan;11(1):108. doi: 10.1097/UPJ.0000000000000481.02. Epub 2023 Nov 2. Urol Pract. 2024. PMID: 37917624 No abstract available.
214 results